Business
The Jack Brewer Foundation and Immune Therapeutics Inc. Announce Medical Equipment Donation Program for the Prevention of Cervical Cancer in Africa to be Unveiled Today at the United Nations
The Jack Brewer Foundation and Immune Therapeutics Inc. Announce Medical Equipment Donation Program for the Prevention of Cervical Cancer in Africa to be Unveiled Today at the United Nations.
About this update from Biostax Corp.
[{"type":"text","content":"\n\n\n\nThe Jack Brewer Foundation and Immune Therapeutics Inc. Announce Medical Equipment Donation Program for the Prevention of Cervical Cancer in Africa to be Unveiled Today at the United Nations\n\n/* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n\n\n\n\n\n\nThe Jack Brewer Foundation and Immune Therapeutics Inc. Announce Medical Equipment Donation Program for the Prevention of Cervical Cancer in Africa to be Unveiled Today at the United Nations\nPR Newswire\nORLANDO, Fla. and DUBLIN, Jan. 8, 2015\n\n\n\nORLANDO, Fla. and DUBLIN, Jan. 8, 2015 /PRNewswire/ -- Immune Therapeutics Inc. (OTC:BB IMUN) – The Jack Brewer Foundation (JBF Worldwide) and Immune Therapeutics, Inc. announced today a first-of-its-kind donation program to improve access to treatment to prevent cervical cancer that until now has been unavailable to the women of Malawi, Africa.  \n\nCervical cancer accounts for approximately 45% of all diagnosed cancer cases in Malawi, and of the 2,300 women diagnosed with cervical cancer each year in Malawi approximately 1,600 of those cases will result in death. In fact, 90% of Africa offers little or no access to oncology care. \n\nThe program is designed to deliver a preventive and simple procedure that can be performed in a clinic setting without the use of a laboratory and further allows for immediate treatment of any precancerous lesions utilizing the Wallach LL100 Cryosurgical systems. The program initially entails the donation of multiple units of these systems to Queen Elizabeth Central Hospital and several clinics throughout Malawi.\n\nAlthough cervical cancer is readily prevented via screening, early detection and treatment of precancerous lesions, most of the eligible women of reproductive health in Africa have never been screened. \"It is time to develop programs for the prevention, early detection, treatment, and palliation of cancer sufferers in Africa,\" said His Excellency Ambassador Jack Brewer, Founder and Executive Director of The Jack Brewer Foundation. \"It is our hope that this innovative donation program will be the first step in sparking further...